WWE now allows fans to get in the ring with their favorite wrestlers with the help of virtual reality.
The company’s Chief Strategy and Financial Officer told Cheddar that the initiative is an extension of the entertainment company’s existing strategy.
“Our social and digital strategy and our direct to consumer strategy over the last seven years, what it’s really allowed us to do is super-serve our biggest fans in a variety of different ways,” George Barrios said.
WWE announced a partnership with NextVR Tuesday morning. The company says that episodes will be free and will feature highlights from select WWE events. Fans will be able to view on both the NextVR app and a new WWE channel.
Barrios, who says the partnership will feature about six ten-minute shows this year, shared his experience with the technology.
“I’ve used it with the [Google] Daydream View,” he said. “I’ve seen it, and it’s absolutely incredible.”
For full interview [click here](https://cheddar.com/videos/wwe-launching-new-virtual-reality-experience).
We spoke with a farmer about how tariffs, trade policy, drought, and packer consolidation are reshaping the economics of American ranching and farming.
John Serafini, CEO of Hawkeye 360, breaks down the company’s 87% revenue growth, global demand for space-based intelligence and plans to scale its business.
Dan Niles, Founder and Portfolio Manager at Niles Investment Management, breaks down NVIDIA’s blowout earnings, 70% growth forecast and AI spending boom.
Edwin Cywinski, CEO of SunScout Holding Limited, explains how solar-powered robotic mowers are transforming lawn care and the company’s plans to scale.
Nathan Bomey, Business Reporter at Axios and author of The Axios Closer newsletter, explains why Wall Street is turning NVIDIA’s AI chips into financial assets.
Jamie Siminoff, Founder and Chief Inventor of Ring, explains the company’s new TAKE encryption standard and its push to put privacy and video data control first
Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.
